Underwent procedure autologous transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

Hematopoietic Stem Cells Bone Marrow Cells, Cultured Bone Marrow Cells Stem Cells T-Lymphocytes Transplants Antilymphocyte Serum Liver T-Lymphocytes, Cytotoxic Lymphocytes Portal Vein Dendritic Cells Fetal Blood Mesenchymal Stromal Cells Kidney Clone Cells CD4-Positive T-Lymphocytes Killer Cells, Natural

Organisms7

Transplantation Chimera Lentivirus Rabbits Mice, Inbred C57BL Rats, Inbred Lew Mice, Inbred BALB C Mice, SCID

Diseases42

Multiple Myeloma Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hodgkin Disease Hematologic Neoplasms Neoplasm, Residual Lymphoma Postoperative Complications Leukemia Leukemia, Myeloid, Acute Myelodysplastic Syndromes Liver Failure Neoplasm Recurrence, Local Disease Progression Cadaver Liver Diseases Acute Disease Kidney Failure, Chronic Anemia, Aplastic Cytomegalovirus Infections Bronchiolitis Obliterans Disease Models, Animal Blood Group Incompatibility Precursor Cell Lymphoblastic Leukemia-Lymphoma Infection End Stage Liver Disease Leukemia, Myeloid Hematologic Diseases Brain Death Liver Cirrhosis Hepatic Veno-Occlusive Disease Liver Failure, Acute Liver Neoplasms Lymphoproliferative Disorders Leukemia, Myelogenous, Chronic, BCR-ABL Positive Primary Graft Dysfunction Chronic Disease Neoplasms Biliary Atresia Delayed Graft Function Ischemia

Chemicals and Drugs35

Melphalan Antigens, CD34 Carmustine Granulocyte Colony-Stimulating Factor Cyclophosphamide Etoposide Busulfan Immunosuppressive Agents Cytarabine Myeloablative Agonists Thalidomide Kanamycin Kinase Vincristine Idarubicin Prednisone Antineoplastic Agents, Alkylating Dexamethasone Antibodies, Monoclonal, Murine-Derived Antibodies, Monoclonal Doxorubicin Antineoplastic Agents Antigens, CD Cyclosporine Tacrolimus HLA Antigens Recombinant Proteins Antilymphocyte Serum Thiotepa Mycophenolic Acid Antigens, Neoplasm ABO Blood-Group System Vidarabine Isoantibodies Isoantigens Interleukin-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment98

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Kidney Transplantation Hematopoietic Stem Cell Mobilization Treatment Outcome Peripheral Blood Stem Cell Transplantation Combined Modality Therapy Cell Transplantation Heart Transplantation Salvage Therapy Lung Transplantation Bone Marrow Purging Leukapheresis Antineoplastic Combined Chemotherapy Protocols Whole-Body Irradiation Remission Induction Retrospective Studies Organ Transplantation Disease-Free Survival Survival Analysis Blood Transfusion, Autologous Survival Rate Follow-Up Studies Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Feasibility Studies Prognosis Blood Component Removal Transplantation, Isogeneic Cell Separation Transplantation, Heterotopic Genetic Therapy Cord Blood Stem Cell Transplantation Prospective Studies Heart-Lung Transplantation Colony-Forming Units Assay Immunomagnetic Separation Blood Cell Count Cell Culture Techniques Immunosuppression Transduction, Genetic Histocompatibility Testing Skin Transplantation Fetal Tissue Transplantation Mesenchymal Stem Cell Transplantation Flow Cytometry Tissue Transplantation Transplantation, Heterologous Multivariate Analysis Corneal Transplantation Polymerase Chain Reaction Risk Factors Brain Tissue Transplantation Facial Transplantation Donor Selection Organ Preservation Tissue and Organ Harvesting Lymphocyte Culture Test, Mixed Postoperative Period Patient Selection Lymphocyte Activation Reoperation Actuarial Analysis Anastomosis, Surgical Biopsy Disease Models, Animal Bone Transplantation Hand Transplantation Lymphocyte Transfusion Neoplasm Transplantation Reconstructive Surgical Procedures Postoperative Care Models, Animal Lymphocyte Depletion Fatal Outcome Blood Transfusion Incidence Cryopreservation Immunotherapy, Adoptive Kaplan-Meier Estimate Risk Assessment Preoperative Care Immunotherapy Immunophenotyping Hepatectomy Surgical Procedures, Operative Cohort Studies Pilot Projects Tissue Preservation Leukocyte Count Immunohistochemistry Severity of Illness Index

Phenomena and Processes20

Graft Survival Time Factors Graft Rejection Transplantation Immunology Graft vs Tumor Effect Hematopoiesis Blood Cell Count Genetic Vectors Transplantation Tolerance Transduction, Genetic Cell Differentiation Histocompatibility Cytotoxicity, Immunologic Lymphocyte Activation Chimerism Immune Tolerance Graft vs Leukemia Effect Regeneration Leukocyte Count Recovery of Function

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups2

Tissue Donors Living Donors

Health Care26

Treatment Outcome Retrospective Studies Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Feasibility Studies Prospective Studies Tissue and Organ Procurement Multivariate Analysis Waiting Lists Risk Factors Donor Selection Postoperative Period Patient Selection Actuarial Analysis Postoperative Care Fatal Outcome Incidence Kaplan-Meier Estimate Risk Assessment Preoperative Care Cohort Studies Age Factors Pilot Projects Severity of Illness Index

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Multiple Myeloma Kidney Transplantation Melphalan Hematopoietic Stem Cell Mobilization Graft Survival Treatment Outcome Peripheral Blood Stem Cell Transplantation Combined Modality Therapy Cell Transplantation Heart Transplantation Lymphoma, Non-Hodgkin Salvage Therapy Antigens, CD34 Lung Transplantation Bone Marrow Purging Recurrence Carmustine Leukapheresis Graft vs Host Disease Granulocyte Colony-Stimulating Factor Cyclophosphamide Antineoplastic Combined Chemotherapy Protocols Whole-Body Irradiation Remission Induction Hematopoietic Stem Cells Retrospective Studies Organ Transplantation Disease-Free Survival Survival Analysis Etoposide Busulfan Hodgkin Disease Time Factors Blood Transfusion, Autologous Hematologic Neoplasms Graft Rejection Survival Rate Immunosuppressive Agents Follow-Up Studies Pancreas Transplantation Islets of Langerhans Transplantation Cytarabine Tissue Donors Transplantation Immunology Transplantation Graft vs Tumor Effect Myeloablative Agonists Transplantation Chimera Thalidomide Bone Marrow Kanamycin Kinase Feasibility Studies Prognosis Blood Component Removal Transplantation, Isogeneic Vincristine Neoplasm, Residual Cells, Cultured Lymphoma Living Donors Cell Separation Hematopoiesis Transplantation, Heterotopic Genetic Therapy Cord Blood Stem Cell Transplantation Idarubicin Postoperative Complications Prospective Studies Prednisone Bone Marrow Cells Leukemia Heart-Lung Transplantation Antineoplastic Agents, Alkylating Dexamethasone Leukemia, Myeloid, Acute Colony-Forming Units Assay Myelodysplastic Syndromes Stem Cells Immunomagnetic Separation Blood Cell Count Cell Culture Techniques Genetic Vectors Immunosuppression Tissue and Organ Procurement Transplantation Tolerance Transduction, Genetic Antibodies, Monoclonal, Murine-Derived Antibodies, Monoclonal Histocompatibility Testing Lentivirus Doxorubicin Skin Transplantation Liver Failure

No FAQ available that match "underwent procedure autologous transplantation"